A systematic review of in vitro models of drug-induced kidney injury

Dimasi, 2016, Innovation in the pharmaceutical industry: new estimates of R&D costs, J Health Econ, 47, 20, 10.1016/j.jhealeco.2016.01.012 Olson, 2000, Concordance of the toxicity of pharmaceuticals in humans and in animals, Regul Toxicol Pharmacol, 32, 56, 10.1006/rtph.2000.1399 Montané, 2021, Epidemiology of drug-related deaths in European hospitals: a systematic review and meta-analysis of observational studies, Br J Clin Pharmacol, 10.1111/bcp.14799 Naughton, 2008, Drug-induced nephrotoxicity, Am Fam Physician, 78, 743 Guengerich, 2011, Mechanisms of drug toxicity and relevance to pharmaceutical development, Drug Metabol Pharmacokinet, 26, 3, 10.2133/dmpk.DMPK-10-RV-062 Jansen, 2020, Humans are animals, but are animals human enough? A systematic review and meta-analysis on interspecies differences in renal drug clearance, Drug Discov Today, 25, 706, 10.1016/j.drudis.2020.01.018 Fuchs, 2011, Biomarkers for drug-induced renal damage and nephrotoxicity—an overview for applied toxicology, AAPS J, 13, 615, 10.1208/s12248-011-9301-x Griffin, 2019, Biomarkers of drug-induced kidney toxicity, Ther Drug Monit, 41, 213, 10.1097/FTD.0000000000000589 Awdishu, 2017, The 6R's of drug induced nephrotoxicity, BMC Nephrol, 18, 10.1186/s12882-017-0536-3 Troth, 2019, Kidney safety assessment: current practices in drug development, 120 De Vries, 2015, A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies, Evid Preclin Med, 2 Ouzzani, 2016, Rayyan—a web and mobile app for systematic reviews, Syst Rev, 5, 210, 10.1186/s13643-016-0384-4 Hartung, 2018, Perspectives on in vitro to in vivo extrapolations, Appl in vitro Toxicol, 4, 305, 10.1089/aivt.2016.0026 Volarevic, 2019, Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity, J Biomed Sci, 26, 25, 10.1186/s12929-019-0518-9 Arechabala, 1999, Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release, J Appl Toxicol, 19, 163, 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H Weber, 2016, Development of a microphysiological model of human kidney proximal tubule function, Kidney Int, 90, 627, 10.1016/j.kint.2016.06.011 Crean, 2015, Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing, Toxicol Vitro, 30, 128, 10.1016/j.tiv.2014.11.015 Musah, 2017, Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip, Nature Biomed Eng, 1, 1, 10.1038/s41551-017-0069 Sjögren, 2018, A novel multi-parametric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery, JAT, 92, 3175 Su, 2016, High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures, Arch Toxicol, 90, 10.1007/s00204-015-1638-y Aschauer, 2015, Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: a transcriptomic study, Toxicol Vitro, 30, 106, 10.1016/j.tiv.2014.10.005 Maschmeyer, 2015, A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents, Lab Chip, 15, 2688, 10.1039/C5LC00392J Choucha-Snouber, 2013, Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip, Biotechnol Bioeng, 110, 597, 10.1002/bit.24707 Chang, 2017, Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity, JCI Insight, 2, 10.1172/jci.insight.95978 Adler, 2016, A quantitative approach to screen for nephrotoxic compounds in vitro, J Am Soc Nephrol, 27, 1015, 10.1681/ASN.2015010060 Astashkina, 2012, A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays, Biomaterials, 33, 4700, 10.1016/j.biomaterials.2012.02.063 Li, 2014, Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells, Mol Pharm, 11, 1982, 10.1021/mp400637s Kandasamy, 2015, Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods, Sci Rep, 5, 12337, 10.1038/srep12337 Luo, 2016, Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro, Kidney Blood Press Res, 41, 10.1159/000452592 Su, 2014, Supervised prediction of drug-induced nephrotoxicity based on interleukin-6 and -8 expression levels, BMC Bioinform, 15, S16, 10.1186/1471-2105-15-S16-S16 Li, 2013, An in vitro method for the prediction of renal proximal tubular toxicity in humans, Toxicol Res, 2, 10.1039/c3tx50042j Morizane, 2015, Nephron organoids derived from human pluripotent stem cells model kidney development and injury, 33, 1193 Dieterle, 2010, Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium, Nat Biotechnol, 28, 455, 10.1038/nbt.1625 Leclerc, 2016, Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver–kidney microfluidic data and pharmacokinetic-system biology models, J Appl Toxicol, 36, 330, 10.1002/jat.3191